Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Risk Stratification of Hepatocarcinogenesis Using a Deep Learning Based Clinical, Biological and Ultrasound Model in High-risk Patients [NA]
A completed clinical trial evaluating a deep-learning model that combines clinical, biological, and ultrasound data to stratify hepatocarcin…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Feasibility Analysis of LCD-SLA 3D Printing Technology for Overall Surgical Planning of Liver Malignant Tumors [NA]
This completed clinical trial assessed the feasibility of LCD-SLA 3D printing to assist in overall surgical planning for liver malignant tum…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms [NA]
This entry notes the completion of a clinical trial evaluating a comprehensive electronic cancer support system for managing cancer-related …
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery [Phase 2]
Phase 2 trial examining hepatic arterial infusion of floxuridine and dexamethasone with bevacizumab in patients with unresectable primary li…
-
CLINICAL_TRIALS trial_result · 2024-12-10Clinical Trial Update: Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy [Phase 4]
A Phase 4 trial evaluating response to immunotherapy in patients with advanced hepatocellular carcinoma and chronic hepatitis C virus infect…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases [Phase 1]
Phase 1 study assessing safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of RO7119929 (TLR7 agonist) in partici…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Triple Recipient Strategy Using Split, Domino, and Auxiliary Techniques
Completed clinical trial evaluating a triple recipient strategy using split, domino, and auxiliary techniques for hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion
This completed clinical trial studied radiation toxicity in the liver using MRI-based perfusion to evaluate effects in liver cancer.
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis [Phase 2]
Phase 2 trial comparing sorafenib plus hepatic arterial infusion versus sorafenib alone in hepatocellular carcinoma with major portal vein t…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma [Phase 2]
Completed Phase 2 trial evaluating camrelizumab combined with apatinib as perioperative treatment for resectable hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC) [NA]
A completed clinical trial evaluating Eye90 Microspheres for unresectable hepatocellular carcinoma and metastatic colorectal cancer, reporti…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer [Phase 3]
Phase 3 trial evaluating nivolumab with or without ipilimumab in combination with trans-arterial chemoembolization for intermediate-stage he…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 1]
Phase 1 trial evaluating the safety of combining navitoclax with sorafenib tosylate in patients with relapsed or refractory solid tumors, in…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC [Phase 2]
A randomized, placebo-controlled, double-blind Phase 2 study evaluating OSI-906 in advanced hepatocellular carcinoma has been terminated. Th…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Emulsion Versus Suspension in Chemoembolization for Hepatocellular Carcinoma [NA]
Completed clinical trial comparing emulsion versus suspension in chemoembolization for hepatocellular carcinoma; results were posted in 2024…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Effect of Tumor Treating Fields (TTFields, 150kHz) Concomitant with Sorafenib for Advanced Hepatocellular Carcinoma (HCC) (HEPANOVA) [Phase 2]
A Phase 2 trial (HEPANOVA) evaluating Tumor Treating Fields at 150 kHz in combination with sorafenib for advanced hepatocellular carcinoma h…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: GEN2 Directed Cancer Immunotherapy Trial [Phase 1]
This update reports completion of a Phase 1 trial of GEN2, GenVivo's cancer immunotherapy, evaluating safety and early signals in hepatocell…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: Hepatic Arterial Infusion Combined With Lenvatinib and Camrelizumab for Unresectable Hepatocellular Carcinoma [Phase 2]
A Phase 2 trial evaluating hepatic arterial infusion combined with lenvatinib and camrelizumab for unresectable hepatocellular carcinoma has…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types [Phase 1]
A Phase 1 study evaluating MT-8421 as monotherapy and in combination with nivolumab in selected advanced solid tumors has been terminated. T…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: TACE Combined with Sintilimab Plus Bevacizumab Biosimilar in Patients with Advanced Hepatocellular Carcinoma (TASK-02) [Phase 2]
A Phase 2 trial (TASK-02) evaluating transarterial chemoembolization plus sintilimab and a bevacizumab biosimilar in advanced hepatocellular…
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 trial of amivantamab as monotherapy in previously treated advanced hepatocellular carcinoma was terminated; results have been posted…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Different Abbreviated MRI for Hepatocellular Carcinoma Diagnosis
This clinical trial update indicates the completion of a study evaluating an abbreviated MRI protocol for diagnosing hepatocellular carcinom…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating sitravatinib as monotherapy and in combination with tislelizumab in participants with unresectable loc…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma [EARLY_Phase 1]
An early Phase 1 clinical trial update reports on the safety and efficacy evaluation of BST06 injection in advanced hepatocellular carcinoma…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II [Phase 2]
Phase 2 IDASPHERE II evaluating idarubicin-loaded beads for chemoembolisation in hepatocellular carcinomas not amenable to interventional ca…